Bank of America’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-147
| Closed | -$27 | – | 8173 |
|
|
2023
Q2 | $27 | Hold |
147
| – | – | ﹤0.01% | 7502 |
|
|
2023
Q1 | $235 | Buy |
147
+114
| +345% | +$232 | ﹤0.01% | 7419 |
|
|
2022
Q4 | $66 | Buy |
33
+25
| +313% | +$62 | ﹤0.01% | 7753 |
|
|
2022
Q3 | $0 | Sell |
8
-305
| -97% | -$1.17K | ﹤0.01% | 8601 |
|
|
2022
Q2 | $1K | Sell |
313
-8
| -2% | -$44 | ﹤0.01% | 7949 |
|
|
2022
Q1 | $3K | Sell |
321
-52
| -14% | -$790 | ﹤0.01% | 8014 |
|
|
2021
Q4 | $8K | Sell |
373
-546
| -59% | -$14.6K | ﹤0.01% | 7757 |
|
|
2021
Q3 | $30K | Sell |
919
-2,816
| -75% | -$103K | ﹤0.01% | 7273 |
|
|
2021
Q2 | $156K | Sell |
3,735
-694
| -16% | -$35.5K | ﹤0.01% | 6255 |
|
|
2021
Q1 | $290K | Buy |
4,429
+3,051
| +221% | +$213K | ﹤0.01% | 5775 |
|
|
2020
Q4 | $91K | Buy |
1,378
+477
| +53% | +$31.1K | ﹤0.01% | 6041 |
|
|
2020
Q3 | $49K | Sell |
901
-289
| -24% | -$22.1K | ﹤0.01% | 6028 |
|
|
2020
Q2 | $114K | Buy |
1,190
+705
| +145% | +$52.5K | ﹤0.01% | 5612 |
|
|
2020
Q1 | $24K | Sell |
485
-3,661
| -88% | -$383K | ﹤0.01% | 6127 |
|
|
2019
Q4 | $341K | Buy |
4,146
+85
| +2% | +$5.96K | ﹤0.01% | 5282 |
|
|
2019
Q3 | $347K | Buy |
4,061
+1,668
| +70% | +$178K | ﹤0.01% | 5319 |
|
|
2019
Q2 | $306K | Buy |
2,393
+328
| +16% | +$47.2K | ﹤0.01% | 5393 |
|
|
2019
Q1 | $372K | Sell |
2,065
-173
| -8% | -$25K | ﹤0.01% | 5201 |
|
|
2018
Q4 | $249K | Buy |
2,238
+558
| +33% | +$72.7K | ﹤0.01% | 5385 |
|
|
2018
Q3 | $227K | Buy |
1,680
+322
| +24% | +$44.4K | ﹤0.01% | 5423 |
|
|
2018
Q2 | $187K | Sell |
1,358
-358
| -21% | -$49.2K | ﹤0.01% | 5456 |
|
|
2018
Q1 | $237K | Buy |
1,716
+500
| +41% | +$68K | ﹤0.01% | 5278 |
|
|
2017
Q4 | $149K | Buy |
1,216
+148
| +14% | +$20.3K | ﹤0.01% | 5553 |
|
|
2017
Q3 | $146K | Buy |
1,068
+32
| +3% | +$4.83K | ﹤0.01% | 5521 |
|
|
2017
Q2 | $182K | Sell |
1,036
-290
| -22% | -$41.2K | ﹤0.01% | 5353 |
|
|
2017
Q1 | $159K | Buy |
1,326
+79
| +6% | +$8.22K | ﹤0.01% | 5415 |
|
|
2016
Q4 | $121K | Buy |
1,247
+111
| +10% | +$10.2K | ﹤0.01% | 5539 |
|
|
2016
Q3 | $107K | Buy |
1,136
+282
| +33% | +$28.3K | ﹤0.01% | 5408 |
|
|
2016
Q2 | $92K | Buy |
854
+48
| +6% | +$5.62K | ﹤0.01% | 5566 |
|
|
2016
Q1 | $96K | Buy |
806
+713
| +767% | +$74.9K | ﹤0.01% | 5505 |
|
|
2015
Q4 | $11K | Buy |
93
+46
| +98% | +$5.93K | ﹤0.01% | 6653 |
|
|
2015
Q3 | $8K | Buy |
47
+4
| +9% | +$767 | ﹤0.01% | 6654 |
|
|
2015
Q2 | $8K | Buy |
43
+16
| +59% | +$2.97K | ﹤0.01% | 6671 |
|
|
2015
Q1 | $4K | Sell |
27
-6
| -18% | -$914 | ﹤0.01% | 6576 |
|
|
2014
Q4 | $5K | Sell |
33
-113
| -77% | -$16.3K | ﹤0.01% | 7297 |
|
|
2014
Q3 | $21K | Sell |
146
-82
| -36% | -$11.9K | ﹤0.01% | 7011 |
|
|
2014
Q2 | $30K | Buy |
228
+210
| +1,167% | +$26.7K | ﹤0.01% | 6982 |
|
|
2014
Q1 | $2K | Sell |
18
-156
| -90% | -$16.9K | ﹤0.01% | 7556 |
|
|
2013
Q4 | $19K | Sell |
174
-101
| -37% | -$9.8K | ﹤0.01% | 7061 |
|
|
2013
Q3 | $31K | Sell |
275
-2,230
| -89% | -$253K | ﹤0.01% | 6686 |
|
|
2013
Q2 | $283K | Buy |
+2,505
| New | +$306K | ﹤0.01% | 5283 |
|
Other funds holding SRGA
RJFSA
BBA
SAM
WWP
Bank of America's SRGA Position: Q3 2023 in Review
Bank of America sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 147 shares — an estimated $27 sold.
Bank of America first reported a position in SRGA in Q2 2013 and held it in 41 quarters. The position peaked at $372K in Q1 2019. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.
- Bank of America reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Bank of America sold 147 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $27.
- Bank of America first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 41 quarters.
- Bank of America's Surgalign Holdings, Inc. Common Stock position peaked at $372K in Q1 2019.
- 4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.
Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.